| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/1993 | WO1993013790A1 A lactoferrin containing therapeutic agent for rheumatism and dermatological and cosmetic compositions containing such agent |
| 07/22/1993 | WO1993013789A1 Hemoregulatory peptides |
| 07/22/1993 | WO1993013788A1 Conjugated peptide derivatives containing an acceptor site for glycosylation and therapeutic uses thereof |
| 07/22/1993 | WO1993013784A1 Platelet transfusion |
| 07/22/1993 | WO1993013783A1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 07/22/1993 | WO1993013782A1 Use of ruthenium red for inhibiting immune response |
| 07/22/1993 | WO1993013775A1 Diaminopyridine compounds for the inhibition of protein glycosylation |
| 07/22/1993 | WO1993013762A1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 07/22/1993 | WO1993013752A1 Improved process for preparing micronized polypeptide drugs |
| 07/22/1993 | WO1993013741A2 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/22/1993 | WO1993013660A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 07/22/1993 | WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 07/22/1993 | DE4201461A1 Agent for selective hyperthermia and chemotherapy of tumours - consists of ferromagnetic particles encapsulated in matrix which is not phagocyted and is able to couple with antitumour agent |
| 07/22/1993 | CA2128017A1 Methods of terminating pregnancy |
| 07/22/1993 | CA2127877A1 Improved process for preparing micronized polypeptide drugs |
| 07/22/1993 | CA2127784A1 Enzyme castration of animals and tumor treatment |
| 07/22/1993 | CA2127688A1 Hemoregulatory peptides |
| 07/22/1993 | CA2127550A1 Multifunctional surface protein of streptococci |
| 07/22/1993 | CA2127540A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | CA2127368A1 Platelet transfusion |
| 07/22/1993 | CA2127295A1 Peptide linkage unit comprising methylene phosphinic acid |
| 07/22/1993 | CA2127250A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127249A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127248A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | CA2127247A1 A novel human kunitz-type protease inhibitor and variants thereof |
| 07/22/1993 | CA2127246A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2125701A1 Hepatitis e virus vaccine and method |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2124217A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | CA2123576A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/22/1993 | CA2117385A1 Use of ruthenium red for inhibiting immune response |
| 07/22/1993 | CA2106368A1 Methods and compositions for treatment of angiogenic disease |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/21/1993 | EP0552106A1 Peptide antagonists of bradykinin |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0551927A1 Method for the treatment of cardiac insufficiency |
| 07/21/1993 | EP0551535A1 Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them |
| 07/21/1993 | EP0551501A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 07/21/1993 | EP0551446A1 A onco-fetal gene, gene product and uses therefor |
| 07/21/1993 | EP0551442A1 Self-assembling ion pair drugs |
| 07/21/1993 | EP0551400A1 Method for treating inflammation using anti-idiotypic antibodies |
| 07/21/1993 | EP0551329A1 Aprotinin analogues |
| 07/21/1993 | EP0551320A1 Protein produced from hirudo medicinalis |
| 07/21/1993 | EP0551308A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 07/21/1993 | EP0551304A1 Fungicidally active compounds |
| 07/21/1993 | EP0551301A1 Cd53 cell surface antigen and use thereof |
| 07/21/1993 | EP0551286A1 Soluble hirudin conjugates |
| 07/21/1993 | EP0536215A4 Neurofibromatosis gene |
| 07/21/1993 | EP0477307A4 Superantigen induced immune non-responsiveness |
| 07/21/1993 | EP0462187B1 Pharmaceutical composition useful in the prevention or treatment of papillomavirus-induced tumours |
| 07/21/1993 | EP0401232B1 A process for pasteurization of aqueous solutions of factor viii |
| 07/21/1993 | CN1074438A Antithrombotic agents |
| 07/20/1993 | US5229501 Expression and use of human fibroblast growth factor receptor |
| 07/20/1993 | US5229500 Brain derived neurotrophic factor |
| 07/20/1993 | US5229496 Amplified expression of recombinant DNA products |
| 07/20/1993 | US5229495 Transforming growth factor |
| 07/20/1993 | US5229494 Receptor for natural killer and non-specific cytotoxic cells |
| 07/20/1993 | US5229493 Chromatigraphically purified protein obtained from pancreatic tumor cells; growth factor stimulant for bovine cells |
| 07/20/1993 | US5229489 Peptide |
| 07/20/1993 | US5229368 Composition for prevention and (or) treatment of Aids |
| 07/20/1993 | US5229367 Prostaglandin inhibitor, phospholipase inhibitor |
| 07/20/1993 | US5229366 Anticoagulants |
| 07/20/1993 | US5229365 Stimulation of pancreatic cells; treatment of diabetes |
| 07/20/1993 | US5229363 Cyclic hexapeptide compounds |
| 07/20/1993 | US5229289 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
| 07/20/1993 | US5229136 Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients |
| 07/20/1993 | US5229115 Adoptive immunotherapy with interleukin-7 |
| 07/20/1993 | US5229109 Cancer treatment; side effect reduction |
| 07/20/1993 | CA1320449C Methods and compositions for thrombolytic therapy |
| 07/20/1993 | CA1320441C Use of growth hormone for nitrogen retention under hypocaloric conditions |
| 07/20/1993 | CA1320440C Natural pulmonary surfactant, method of preparation and pharmaceutical compositions |
| 07/20/1993 | CA1320350C Combination lock for blood identification system |
| 07/18/1993 | CA2087379A1 Pseudopeptidic derivatives having an antigonistic activity for bradykinine, process for their preparation and pharmaceutical compositions containing them |
| 07/16/1993 | CA2087328A1 Therapeutically active peptides and pseudopeptides derivatives in the blood coagulation process, a process for their preparation and pharmaceutical compositions containing them |
| 07/15/1993 | EP0559647A4 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase. |
| 07/14/1993 | EP0551200A1 Protein phosphatase inhibitors for use in therapy |
| 07/14/1993 | EP0551084A2 Human antithrombin-III preparation |
| 07/14/1993 | EP0551077A2 Pharmaceutical composition comprising atrial nutriuretic peptide for treatment of adult respiratory distress syndrome |
| 07/14/1993 | EP0550946A2 Genes encoding porcine zona pellucida protein PZP-4, expression thereof and contraceptive vaccines comprising expressed (poly)peptides |
| 07/14/1993 | EP0550756A1 Interleukin 6 composition and production thereof |
| 07/14/1993 | EP0550691A1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides. |
| 07/14/1993 | EP0550661A1 Gro genes, proteins, and uses thereof |
| 07/14/1993 | EP0550629A1 Metal ion mediated receptor binding of polypeptide hormones |
| 07/14/1993 | EP0550625A1 Bmp-5 derivatives |
| 07/14/1993 | EP0550529A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 07/14/1993 | EP0550516A1 Method for inhibiting the infectivity of human immunodeficiency virus |
| 07/14/1993 | EP0550506A1 Novel chemotactic factor |
| 07/14/1993 | EP0550482A1 Methods for inhibiting rejection of transplanted tissue |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/14/1993 | EP0550458A1 Bone growth stimulator. |
| 07/14/1993 | EP0550450A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 07/14/1993 | EP0497928A4 Yeast-derived epidermal growth factor/urogastrone-like products |
| 07/14/1993 | EP0320507B1 Scaled-up production of liposome-encapsulated hemoglobin |
| 07/14/1993 | CN1074220A Cell-free ciliary neurotrophic factor/receptor complex |
| 07/14/1993 | CN1074133A Micro-molecule glucoprotein biologics and its preparation |
| 07/13/1993 | US5227496 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same |
| 07/13/1993 | US5227471 Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma |
| 07/13/1993 | US5227469 Platelet aggregation inhibitors from the leech |